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Abstract
Endothelial cells represent an important barrier between the intravascular compartment and extravascular tissues, and
therefore serve as key sensors, communicators, and amplifiers of danger signals in innate immunity and inflammation.
Double stranded DNA (dsDNA) released from damaged host cells during injury or introduced by pathogens during
infection, has emerged as a potent danger signal. While the dsDNA-mediated immune response has been extensively
studied in immune cells, little is known about the direct and indirect effects of dsDNA on the vascular endothelium. In this
study we show that direct dsDNA stimulation of endothelial cells induces a potent proinflammatory response as
demonstrated by increased expression of ICAM1, E-selectin and VCAM1, and enhanced leukocyte adhesion. This response
was dependent on the stress kinases JNK and p38 MAPK, required the activation of proinflammatory transcription factors
NFkB and IRF3, and triggered the robust secretion of TNFa for sustained secondary activation of the endothelium. DNA-
induced TNFa secretion proved to be essential in vivo, as mice deficient in the TNF receptor were unable to mount an acute
inflammatory response to dsDNA. Our findings suggest that the endothelium plays an active role in mediating dsDNA-
induced inflammatory responses, and implicate its importance in establishing an acute inflammatory response to sterile
injury or systemic infection, where host or pathogen derived dsDNA may serve as a danger signal.
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Introduction
The endothelium serves as a key anatomic and functional
barrier separating circulating cells and molecules of the vascular
space, from the stroma and tissue-specific cells of solid organs.
As such endothelial cells play a critical role in inflammation by
sensing danger signals, and subsequently initiating the expression
of cellular adhesion factors and the secretion of inflammatory
cytokines [1,2]. During an infection or sterile injury, pathogens
and damaged host cells release danger signals such as lipopoly-
saccharides (LPS), peptidoglycans (PGN), high-mobility group
protein-1 (HMGB1), and double stranded DNA (dsDNA) into
circulation [3,4,5,6,7,8]. Many of these danger signals have been
shown to activate innate immune and inflammatory responses in
endothelial cells [9,10,11,12]. However, little is known about the
direct effects of dsDNA on the vascular endothelium.
DNA has recently emerged as a potent activator of the innate
immune system. Mammalian cells are exposed to dsDNA that
is released from damaged host cells during tissue injury, or
introduced by DNA viruses and intracellular bacteria during
infection [13,14,15,16,17]. Many cytosolic receptors including Z-
DNA binding protein 1 (ZBP1) and gamma-interferon-inducible
protein 16 (IFI16) have been identified for sensing dsDNA [17,18].
Signaling through these receptors triggers the activation of kinases
such as TBK1 and Ikki, and the downstream phosphorylation of
transcription factors IRF3 and NFkB [15]. Numerous investi-
gations have revealed that dsDNA stimulation elicits a robust
antiviral and inflammatory response in innate immune cells
[15,19,20,21]. Dendritic cells have been shown to secrete large
amounts of interferon a/b, as well as chemokines IP10 and CCL5,
in response to dsDNA [15]. In macrophages, dsDNA stimulation
has been shown to trigger the robust production of proinflamma-
tory cytokines IL1b and IL18 [20]. A recent study revealed that
during sterile drug-induced liver injury, sinusoidal endothelial cells
can also sense dsDNA from damaged hepatocytes and initiate an
acute inflammatory response, however the mechanism remains
unknown [14]. While endothelial cells are well known to respond
to indirect stimulation by cytokines [22], their role as primary
responders to direct stimulation by danger signals such as dsDNA
is just recently emerging. The purpose of this study was to in-
vestigate the inflammatory response of endothelial cells to direct
dsDNA treatment.
In this work we show for the first time that endothelial cells
exposed to dsDNA trigger the activation of NFkB and MAPK
pathways, including JNK and p38. This leads to increased
expression of ICAM1, VCAM1 and E-selectin, and results in
functional leukocyte adhesion. We demonstrate that endothelial
sensing of dsDNA induces robust expression and secretion of
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TNFa, which mediates sustained secondary activation of the
endothelium. Mice deficient in the TNF receptor are unable to
mount an acute inflammatory response to DNA. Furthermore,
both NFkB and IRF3 are required for the production of the TNFa
in response to dsDNA. This study suggests a possible role for
endothelial cells in mediating dsDNA-induced inflammatory
responses, and implicates their importance in establishing an
acute inflammatory response to systemic infection or sterile injury
such as ischemia-reperfusion injury, where pathogen or host
dsDNA may serve as a danger signal.
Results
Endothelial activation and leukocyte adhesion is
triggered by dsDNA stimulation
Endothelial activation is an early event through which pa-
thogen-associated molecular patterns induce inflammation during
infection and tissue injury. Recent studies have established the role
of dsDNA as a potent activator of the innate immune system [23].
For evaluating endothelial activation in response to DNA sti-
mulation, we treated endothelial cells with synthetic B-form
Poly(dA-dT):Poly(dA-dT) (hereafter referred to as dsDNA), a
known intracellular DNA ligand [15]. dsDNA treatment resulted
in increased expression of endothelial adhesion molecules ICAM1,
VCAM1, and E-selectin (Figure 1a). The greatest increase in
gene expression was observed for VCAM1 (Figure 1a). Adhesion
molecules play a central role in leukocyte recruitment by re-
gulating their attachment to the endothelium. To determine if
dsDNA stimulation results in increased leukocyte adhesion,
confluent monolayers of endothelial cells were treated with
dsDNA, and then co-cultured with cell membrane dye-labeled
peripheral blood leukocytes. TNFa stimulated endothelial cells
were used as a positive control for measuring leukocyte adhesion
under inflammatory conditions. dsDNA stimulation of RHMEC
lead to significantly enhanced binding of leukocytes (3.5 fold), in
comparison to Lipofectamine treated cells (Figure 1b). Our results
indicate that dsDNA acts as a potent activator of the endothelium
by increasing the expression of adhesion molecules and directly
enhancing leukocyte adhesion.
dsDNA-induced activation of NFkB and MAPK pathways
NFkB and MAPK pathways are known to play an important role
in regulating the expression of endothelial adhesion molecules [22].
Given that dsDNA stimulation leads to increased expression of
adhesion molecules, we examined the activation of NFkB and
MAPK pathways in response to dsDNA. For evaluating NFkB
activation, a reporter clone of endothelial cells that synthesizes GFP
in response to NFkB activation was utilized. dsDNA stimu-
lation of NFkB endothelial cell reporters resulted in elevated levels
of GFP in comparison to Lipofectamine stimulated cells, suggesting
NFkB activation by dsDNA (Figure 2a). A nuclear ELISA for NFkB
activation further confirmed that dsDNA induced dose-dependent
activation of NFkB in endothelial cells after 6 hours of stimulation
(Figure 2b). For evaluating MAPK activation, phosphorylated
protein levels of JNK, p38, and ERK1/2 were measured in
endothelial cells stimulated with dsDNA for 6 hours. Endothelial
cells treated with dsDNA showed elevated levels of phosphorylated
JNK and p38 in comparison to Lipofectamine treated cells
(Figure 2c). However, levels of phosphorylated ERK1/2 were
similar in both dsDNA stimulated and control cells (Figure 2c).
These results suggest that dsDNA induces the activation of NFkB,
JNK and p38 signaling pathways in endothelial cells, but not
ERK1/2.
Regulation of adhesion molecule expression by
modulation of NFkB and MAPK pathways
We next sought to determine whether dsDNA induced
activation of NFkB, JNK, and p38 pathways was required for
increased expression of endothelial adhesion molecules. Endothe-
lial cells were treated with dsDNA for 4 hours in the presence
or absence of PDTC, SP600125, or SB202190, known inhibitors
of NFkB [24], JNK [25], and p38 MAPK [26] pathways,
respectively. Inhibition of NFkB, JNK, and p38 resulted in
significantly reduced expression of ICAM1, VCAM1 and E-
selectin, suggesting that all three signaling pathways are involved
in dsDNA stimulated endothelial activation (Figure 2d). Inhibition
of NFkB was most potent at reducing expression of these adhesion
molecules (Figure 2d). Given that JNK and p38 MAPK are known
activators of the AP1 family of transcription factors [27], our
results suggest that transcription factors AP1 and NFkB may be
required for dsDNA-induced endothelial activation.
NFkB and IRF3 are required for dsDNA-induced TNFa
production
TNFa is an important mediator of inflammation, as it acts on
vascular endothelial cells to promote expression of adhesion
molecules [28]. Having demonstrated mechanistically how direct
stimulation of endothelial cells with dsDNA results in the ex-
pression of adhesion molecules, we next sought to investigate
whether dsDNA induced TNFa production. dsDNA stimulation
of endothelial cells resulted in upregulation of TNFa expression
and robust secretion of TNFa into the culture supernatant,
compared to Lipofectamine stimulation (Figure 3a,b). To deter-
mine the transcription factors necessary for TNFa production in
Figure 1. dsDNA induced activation of the endothelium. (a) Q-PCR for expression of ICAM-1, VCAM-1, and E-Selectin in endothelial cells after
stimulation with dsDNA (2 mg/ml) for 4 hours. (b) Leukocytes adhesion to the endothelial cells stimulated with dsDNA (2 mg/ml), TNFa (10 ng/ml), or
mock transfected with Lipofectamine alone (control) for 12 hours. (*P,0.05 compared to control).
doi:10.1371/journal.pone.0019910.g001
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response to dsDNA, we used transgenic knockout mouse
embryonic fibroblasts (MEFs). Wildtype MEFs (WT) stimulated
with dsDNA induced significant TNFa secretion after 24 hours
(Figure 4c). Conversely, MEFs deficient in TBK1 and IKKe
(TBK1/IKKe DKO), kinases necessary for IRF3 activation, failed
to produce TNFa (Figure 3c). Similarly, dsDNA-stimulated MEFs
deficient in IKKa and IKKb (IKKa/IKKb DKO), kinases
essential for NFkB activation, also failed to produce TNFa
(Figure 3c).To determine whether dsDNA-induced activation
of NFkB, JNK, and p38 MAPK pathways was required for
TNFa production, endothelial cells were treated with dsDNA for
24 hours in the presence or absence of known inhibitors of NFkB,
JNK and p38 MAPK pathways. Inhibition of NFkB, JNK, and
p38 MAPK significantly reduced TNFa production, although the
reduction was more pronounced for NFkB and JNK inhibitors in
comparison to p38 MAPK inhibitor. These results suggest that all
three signaling pathways are involved in dsDNA stimulated TNFa
production (Figure 3d). Together, these data suggest that dsDNA-
induced TNFa secretion is dependent on both IRF3 and NFkB
activation, and JNK signaling pathways.
We then sought to determine whether dsDNA-induced TNFa
influences overall endothelial activation, since the expression of
many adhesion molecules, such as VCAM1, is indirectly promoted
by proinflammatory cytokines [22]. Using cycloheximide, a classic
inhibitor of protein translation, we first clarified what portion
of dsDNA-induced VCAM1 expression is from direct sensing of
dsDNA and what part is from secondary indirect activation,
requiring de novo protein synthesis. After 4 hours of dsDNA
stimulation, VCAM1 expression, in the presence or absence of
cycloheximide, was approximately equal (Figure 3e). However,
after 12 hours of dsDNA stimulation, VCAM1 expression in the
Figure 2. dsDNA activates NFkB and MAPK pathways, which
modulate adhesion molecule expression in endothelium. (a)
Fluorescence histogram of NFkB reporter clone of endothelial cells
treated with Lipofectamine alone (control) or dsDNA (2 mg/ml) for
16 hours. (b) ELISA for NFkB activity in endothelial cells stimulated with
a dose of dsDNA (0 to 4 mg/ml) for 6 hours. (c) Phosphorylated protein
levels in endothelial cells stimulated with dsDNA (2 mg/ml) for 6 hours.
(d) Q-PCR for expression of ICAM-1, VCAM-1, and E-Selectin in RHMECs
after stimulation with dsDNA (2 mg/ml) for 4 hours in the presence or
absence of PDTC (PD), SP600125 (SP), or SB202190 (SB), which are
inhibitors of NFkB, JNK, and p38 MAPK pathways, respectively. (*P,0.05
compared to control, #P,0.05 and ##P,0.01 compared to dsDNA
alone.)
doi:10.1371/journal.pone.0019910.g002
Figure 3. dsDNA mediated TNFa secretion for sustained
secondary activation of the endothelium. (a) Q-PCR for expression
of TNFa in endothelial cells after stimulation with dsDNA (.5 or 4 mg/ml)
or mock transfected with Lipofectamine for 12 hours. (b) ELISA for TNFa
in culture supernatant of endothelial cells stimulated with dsDNA (.5 or
4 mg/ml) or mock transfected with Lipofectamine for 24 hours. (c) ELISA
for TNFa in supernatants of wildtype MEFs (WT), TBK1/IKKe DKO MEFs
(TBK1/IKKe DKO), and IKKa/IKKb DKO MEFs (IKKa/IKKb DKO) stimulated
with 4 mg/mL of dsDNA for 24 hours. (d) ELISA for TNFa in supernatants
of endothelial cells after stimulation with dsDNA (4 mg/ml) for 24 hours
in the presence or absence of PDTC (PD), SB202190 (SB) or SP600125
(SP) which are inhibitors of NFkB, p38 MAPK and JNK pathways,
respectively. (e) Q-PCR for expression of VCAM1 in endothelial cells
stimulated with dsDNA (1 mg/ml) for 4 or 12 hours, in the presence or
absence of TNFa neutralizing antibody (+Anti-TNFa) or cycloheximide
(+CHX). (*P,0.05 compared to control, #P,0.05 compared to dsDNA
alone.)
doi:10.1371/journal.pone.0019910.g003
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presence of cycloheximide was reduced to the level in unstimu-
lated cells, whereas expression in the absence of cycloheximide
remained high (Figure 3e). These data suggested that at an early
time point, most of the measured VCAM1 expression was from
direct sensing of dsDNA by endothelial cells, and that at later
time points, VCAM1 expression was sustained by a secondary
mechanism which required protein synthesis. Given the secretion
of TNFa in response to dsDNA stimulation, we utilized a TNFa
neutralizing antibody to investigate whether this secondary
mechanism for sustained VCAM1 expression was due to the
paracrine actions of TNFa. After 4 hours of dsDNA stimula-
tion, VCAM1 expression, in the presence or absence of TNFa
neutralizing antibody, was nearly similar (Figure 3e). In contrast,
at 12 hours, VCAM1 expression in the presence of TNFa neu-
tralizing antibody was curtailed to the level in unstimulated cells,
suggesting that dsDNA-induced TNFa is required for sustained
secondary activation of the vascular endothelium.
dsDNA-mediated acute inflammation is dependent on
TNFa
To evaluate the in vivo role of TNFa in acute inflammation
triggered by dsDNA, we developed an in vivo model of dsDNA-
induced inflammation. We injected complexed-DNA, as well as
complexed-DNAse digested DNA, intraperitoneally (i.p.) into
mice. After 16 hours, mice injected with dsDNA had abundant
neutrophils in their abdominal cavities (Figure 4a), indicated by
the staining of peritoneal lavage cells with the neutrophil marker
Ly-6G. However, mice injected with DNAse digested DNA had
minimal neutrophil infiltration (Figure 4a), in agreement with
prior reports suggesting that DNAse digestion renders DNA inert
to innate immune system. Mice deficient in the TNFa receptor
(TNFR12/2) also had significantly reduced neutrophil accumu-
lation when injected with dsDNA, compared to abundant
neutrophils in TNFR1+/+ mice (Figure 4b). Taken together,
these results demonstrate that detection of dsDNA triggers acute
inflammation dependent on TNFa signaling.
Discussion
The endothelium exists at the interface between the vascular
and tissue compartments, and is responsible for communicating
danger signals during infection or sterile injury. Recently, dsDNA
from pathogens and dying host cells was found to be a potent
danger signal, capable of activating immune and inflammatory
responses in many types of innate immune cells [13,15,16,17].
In the current study we explore the consequences of directly
stimulating endothelial cells with dsDNA. We show that dsDNA
stimulation leads to expression and secretion of TNFa, as well as
upregulation of surface adhesion molecules that facilitate leukocyte
recruitment. These responses depend on activation of upstream
MAP kinases JNK and p38, as well as activation of transcription
factor NFkB. Furthermore, we provide evidence demonstrating
that IRF3 and NFkB are both required for dsDNA-induced TNFa
secretion, and show that TNFa is required for sustained secondary
activation of the vascular endothelium.
The cellular response to dsDNA can be divided into two
categories, a proinflammatory component mediated by the cy-
tokines such as TNFa and IL1b, and an antiviral component
mediated by type I interferons [20]. While the molecular path-
ways of the interferon response to dsDNA have been intensively
investigated, the inflammatory arm has received comparatively less
attention. TNFa and IL1b are arguably the most potent cytokines
involved in inducing inflammation. They play a specific role
in endothelial activation by inducing expression of cell surface
adhesion molecules [22]. Investigations of dsDNA-induced
inflammation have largely focused on the secretion of IL1b
[20,29]. Stimulation of cells with dsDNA triggers the robust
secretion of IL1b by activating the inflammasome through the
cytosolic DNA sensor absent in melanoma 2 (AIM2) and the
endosomal DNA sensor TLR9, both of which are expressed in a
cell type specific manner [29,30]. These sensors bind dsDNA, and
associate with inflammasome adaptor molecules for caspase-1
mediated secretion of IL1b, which can indirectly stimulate the
endothelium [14,29]. While the molecular details of dsDNA-
induced IL1b secretion have been extensively investigated, the
mechanism by which dsDNA triggers secretion of TNFa and
its role in dsDNA-mediated inflammation remains relatively
unexplored.
In this study, we focus on dsDNA-induced NFkB activation and
TNFa secretion, and explore its ability to initiate and amplify a
proinflammatory response in endothelial cells. We chose this cell
type because of its unique location at the interface between tissue
and vascular compartments, its likelihood of being exposed to
danger signals, and because of its important functional role in
recruiting immune cells to areas of injury. Endothelial cells are
known to respond to indirect stimulation by proinflammatory
cytokines commonly secreted in response to dsDNA [22], but their
ability to directly sense dsDNA has not been examined. A recent
study showed that free dsDNA released from apoptotic cells can
directly stimulate endothelial cells to secrete IL1b and IL18 [14],
however the mechanism remains unknown, and the subsequent
activation of the endothelium unexplored.
Figure 4. dsDNA induced acute inflammation depends on
TNFa. (a,b) Representative fluorescence histograms of Ly-6G expres-
sion on peritoneal exudate cells (PEC) in mice injected 16 h earlier with
saline (control), 2 mg/g of dsDNA, or 2 mg/g of DNAse digested DNA.
The Ly-6G+ gate represents neutrophils. Neutrophil numbers in PEC of
TNFR1+/+ and TNFR12/2 mice 16 h after i.p. challenge with 2 mg/g of
dsDNA. Neutrophil numbers in PEC were determined by multiplying the
total cell numbers by the percentage of Ly-6G+ cells. (*P,0.05
compared to control, #P,0.05 compared to dsDNA alone, a P,0.05
compared to TNFR1+/+ mice.)
doi:10.1371/journal.pone.0019910.g004
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In this report, we established that dsDNA sensing by endothelial
cells leads to potent expression and secretion of TNFa. This is in
agreement with prior studies using other cell types, which showed
that undigested mammalian dsDNA induced TNFa secretion in
macrophages [31], and enhanced expression of TNFa in dsDNA
stimulated hepatocytes [32]. We also showed that dsDNA-
mediated TNFa secretion was abrogated in MEFs deficient in
kinases necessary for NFkB and IRF3 activation suggesting that
both transcription factors are necessary for the response, which is
analogous to LPS-induced TNFa secretion [33,34]. Finally, we
discovered TNFa as an essential mediator of dsDNA-induced
acute inflammation, as mice lacking the TNF receptor exhibited
a dramatic reduction in the inflammatory response to dsDNA
stimulation in vivo. Although, it is important to note that
eliminating the TNFa signaling did not completely abrogate the
inflammatory response. Our studies did not resolve if the minor
response observed in mice lacking the TNF receptor was due to
direct induction of adhesion molecules by dsDNA or indirect
contribution of some other cytokine(s). Dissecting the relative
contributions of direct and indirect endothelial cell activation to
this response, establishing the cellular source of TNFa, and
determining possible involvement of other cytokine(s) will require
further investigation.
Results from this study may have important implications in host
defense and sterile injury. Direct sensing of dsDNA by the vascular
endothelium suggests that endothelial cells may play an active role
in mounting immune responses to systemic infection. In particular,
DNA viruses such as cytomegalovirus (CMV), Epstein-Barr virus
(EBV) and Herpes simplex virus-1 (HSV1) have been shown to
infect the vascular endothelium resulting in dysfunction and injury
that plays an important role in viral pathogenesis [10,35,36].
Endothelial cells may also be exposed to host dsDNA when cells
die in vivo in the absence of infection due to sterile injury. During
an ischemic injury, such as a myocardial infarction, damaged
myocytes release genomic dsDNA locally into circulation [37]
where it can stimulate a potent inflammatory response in
endothelial cells, including a rapid influx of neutrophils to the
site of injury. This sterile inflammation may contribute to the pa-
thogenesis of acute ischemic injuries, as well as other forms of
sterile injury including drug-induced toxicity. More studies are
needed to better understand the precise role dsDNA plays in
activating the endothelium during infection or sterile injury.
Another area of relevance for endothelial dsDNA-sensing is
the response to gene therapy. The endothelium represents an
attractive target for gene therapy because of its accessibility by
intravenous infusion and its ability to communicate signals to the
tissue compartment of solid organs. However, designing gene
therapy vectors that minimize endothelial cell activation has proven
to be challenging [38]. This could be related to the fact that gene
therapy vectors are often derived from dsDNA-viruses, complexed
plasmid dsDNA, or naked dsDNA, which can induce innate
immune and inflammatory responses. Manipulating the immune
and inflammatory responses of dsDNA-stimulated endothelial cells
using knowledge of the underlying molecular machinery represents
a unique opportunity to overcome these challenges.
Materials and Methods
Materials
Dulbecco’s Modified Eagle Medium (DMEM), penicillin-
streptomycin, and fetal bovine serum (FBS) were acquired from
Invitrogen Life Technologies (Carlsbad, CA). Pyrrolidine dithio-
carbamate (PDTC), SP600125, SB202190 were obtained from
Tocris bioscience (Ellisville, MO). Synthetic polydeoxynucleotide,
poly(dA-dT):poly(dA-dT) dsDNA, was purchased from Amersham
Biosciences. MCDB-131-complete medium was obtained from
VEC Technologies (Rensselaer, NY). Rat tumor necrosis factor-a
(TNFa) was purchased from R&D Systems (Minneapolis, MN).
Transfection of cells
Primary rat heart microvessel endothelial cells were acquired
from VEC Technologies and maintained in MCDB-131 medium
supplemented with 10% FBS, 10 ng/ml EGF, 1 mg/ml hydro-
cortisone, 200 mg/ml EndoGro, 90 mg/ml heparin, and 1%
antimycotic solution. For transfections, endothelial cells were
switched to DMEM media supplemented with 10% FBS, and 2%
penicillin-streptomycin. dsDNA transfections were performed by
using Lipofectamine LTX (Invitrogen) at a ratio of 1.5:1 (volume/
weight) with dsDNA as per manufacturer’s protocol. For ex-
periments involving the use of inhibitors, cells were pretreated with
PDTC (5 mg/ml), SP600125 (20 mM), or SB202190 (10 mM) in
DMEM for 1 h before dsDNA stimulation and during stimulation.
For some experiments, endothelial cells were pretreated with
a TNFa neutralizing antibody (2 mg/ml; R&D Systems), or
cycloheximide (20 mg/ml; Sigma Alrich) for 1 hour before dsDNA
stimulation and during stimulation.
Mouse embryonic fibroblasts (MEFs) weremaintained in DMEM
media supplemented with 10% FBS, and 2% penicillin-streptomy-
cin. dsDNA transfections were performed as described above.
Unless otherwise noted, all experiments were done three times.
Real time polymerase chain reaction
RNA was extracted from cells using nucleospin RNA II kit
(Macherey-Nagel Inc., Bethlehem, PA) according to the manu-
facturer’s instructions. Quantitative Reverse Transcription PCR
was performed using the Superscript III two-Step qRT-PCR kit
purchased from Invitrogen (Carlsbad, CA). 500 ng of cellular
RNA was reverse transcribed according to the manufacturer’s
directions. Real-time quantitative PCR was performed using the
Stratagene (La Jolla, CA) MX5000P QPCR system. Each reaction
was carried out with 10 ng cDNA and 0.6 mM primers. During
amplification, the cycling temperatures were 95uC for 15 seconds,
57uC for 1 minute and 72uC for 30 seconds. The following
primers were used for amplifying DNA: E-Selectin forward
primer: CAACACATCCTGCAGTGGTC; E-Selectin reverse
primer: AGCTGAAGGAGCAGGATGAA; ICAM-1 forward
primer: CCTCTTGCGAAGACGA GAAC; ICAM-1 reverse
primer: ACTCGCTCTGGGAACGAATA; VCAM-1 forward
primer: TGAAGGGGCTACATCCACAC; VCAM-1 reverse
primer: GACCGTGCAGT TGACAGTGA; TNFa forward
primer: GTCTGTGCCTCAGCCTCTTC; TNFa reverse prim-
er: GCTTGGTGGTTTGCTACGAC; b-actin forward primer:
GTCGTACCACTGGCATTGTG; and b-actin reverse primer:
CTCTCAGCTGTGGTGG TGAA. By using the comparative
cycle threshold method, all data were normalized to endogenous
reference gene b -actin and then compared with appropriate
controls for calculation of fold change.
TNFa ELISA
Supernatants from endothelial cells and MEFs were used
to determine the amount of rat TNFa and mouse TNFa,
respectively, that was secreted as measured by ELISA (R&D
Systems) according to the manufacturer’s protocol.
Fluorescent Microscopy
Images were acquired using a Zeiss 200 M microscope (Carl
Zeiss Inc., Thornwood, NY). The fluorescence images were
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captured using a CCD camera (Carl Zeiss Inc.) and Zeiss imaging
software (Axiovision LE).
Leukocyte adhesion experiments
Peripheral blood leukocytes were purified from heparinized
peripheral blood of rat using Histopaque density gradient (Sigma)
according to manufacturer’s instructions. Leukocytes were labeled
with CM-DiI (2.5 mg/ml) at 37uC for 10 minutes and then added
to endothelial cells that were stimulated with dsDNA (2 mg/ml) or
TNFa (10 ng/ml) for 12 hours. Leukocytes were allowed to
adhere for 60 minutes at 37uC and then washed 3 times with PBS
for removing non adhered cells. Fluorescence images were
captured and analyzed using Image J software (National Institute
of Health, Bethesda, MD) to estimate the degree of leukocyte
adhesion to endothelial cells.
Construction of NFkB reporter clone of endothelial cells
NFkB reporter plasmid consisted of multiple response elements
upstream of destabilized green fluorescent protein gene that
encodes for d2EGFP reporter protein [39]. The details describing
the construction of NFkB reporter clone of endothelial cells are
reported elsewhere [40]. Briefly, endothelial cells (2.5 million) were
electroporated with the NFkB reporter plasmid (10 mg) using a
BTX Electro Cell Manipulator 600 (Biotechnology and Experi-
mental Research, San Diego, CA) at 280 V and 960 mF. Stably
transfected clones were selected by addition of geneticin to a final
concentration of 700 mg/ml. The clone that exhibited maximum
shift in fluorescence upon stimulation with TNFa was used in
experiments.
Measuring NFkB and MAPK activity
Endothelial cells were stimulated with different dose of ds-
DNA ranging from 0 to 4 mg/ml for 6 hours. Nuclear extract
was prepared from cells using Panomics Nuclear Extraction
Kit (Affymetrix, Inc., Santa Clara, CA) as per manufacturer’s
protocol. Nuclear extracts were kept frozen in 280uC until further
analysis. NFkB activity was determined by estimating the levels
of NFkB p65 protein in the nuclear extract using ELISA kit
(TransFactor NFkB p65 kit, Clontech, Mountain View, CA)
according to manufacturer’s instruction. Samples were normalized
by total protein concentration of the nuclear extract, determined
by Bradford reagent.
Endothelial cells were stimulated with dsDNA (2 mg/ml) for
6 hours in 96 well plate. Phosphorylated protein levels of JNK,
p38 MAPK, and ERK1/2 were determined using cell based
ELISA kit (RayBio Cell-Based ERK1/2 ELISA Sampler Kit, Ray
Biotech Inc., Norcross, GA) as per manufacturer’s instructions.
Animals
C57BL/6 and TNFR12/2 mice were purchased from Jackson
Laboratory. All animal protocols were approved by Massachusetts
General Hospital Subcommittee on Research Animal Care.
dsDNA-induced inflammation
dsDNA was complexed with LyoVec transfection reagent
according to the manufacturer’s protocol (Invivogen). DNAse I
digested DNAwas prepared by treating 100 mg of DNAwith 5 U of
DNAse I (Ambion) at 37 C for 30 minutes. DNAse was then heat
inactivated, and the digested DNA was complexed with LyoVec.
Mice were injected intraperitoneally with dsDNA (2 mg/kg) in
.1 ml PBS, DNAse digested DNA (2 mg/kg) in .1 mL PBS, or PBS
alone. At 16 hours after challenge, the numbers of neutrophils (Ly-
6G+) in the peritoneumwere evaluated as previously described [41].
For each condition, 5 animals were used.
Statistical Analysis
Results are reported as mean 6 standard deviation. Statistical
analysis was performed using the Student’s t-test, with P,0.05
considered significant.
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